Incretin-based Therapies for Type 2 Diabetes Mellitus: Effects on Insulin Resistance

By  

Current Diabetes Reviews, Vol. 9, Iss. 5, 2013-09 ,pp. : 412-417

Bentham Science Publishers

Access to resources Recommend Favorite

Emerging Incretin-Based Therapies for Type 2 Diabetes: Incretin Mimetics and DPP-4 Inhibitors

By  

Current Diabetes Reviews, Vol. 4, Iss. 2, 2008-05 ,pp. : 101-109

Bentham Science Publishers

Access to resources Recommend Favorite

Metformin in patients with type 2 diabetes mellitus: reconsideration of traditional contraindications

By Rachmani R.   Slavachevski I.   Levi Z.   Zadok B.-S.   Kedar Y.   Ravid M.  

European Journal of Internal Medicine, Vol. 13, Iss. 7, 2002-10 ,pp. : 428-433

Elsevier

Access to resources Recommend Favorite

Type 2 Diabetes and Heart Failure: Challenges and Solutions

By  

Current Cardiology Reviews, Vol. 12, Iss. 3, 2016-07 ,pp. : 249-255

Bentham Science Publishers

Access to resources Recommend Favorite

Efficacy and safety over 26 weeks of an oral treatment strategy including sitagliptin compared with an injectable treatment strategy with liraglutide in patients with type 2 diabetes mellitus inadequately controlled on metformin: a randomised clinical trial

By Charbonnel B.   Steinberg H.   Eymard E.   Xu L.   Thakkar P.   Prabhu V.   Davies M.   Engel S.  

Diabetologia, Vol. 56, Iss. 7, 2013-07 ,pp. : 1503-1511

Springer Publishing Company

Access to resources Recommend Favorite